2,890
Views
26
CrossRef citations to date
0
Altmetric
Research Article

In vitro and in vivo evaluation of folate receptor-targeted a novel magnetic drug delivery system for ovarian cancer therapy

, , &
Pages 926-937 | Received 27 Nov 2017, Accepted 08 Feb 2018, Published online: 19 Feb 2018

References

  • Sheng Q, Liu J. The therapeutic potential of targeting the EGFR family in epithelial ovarian cancer. Br J Cancer. 2011;104:1241–1245.
  • Jung K, Rezska R. Mitochondria as subcellular targets for clinically useful anthracyclines. Adv Drug Deliv Rev. 2001;49:87–105.
  • Chomoucka J, Drbohlavova J, Huskab D, et al. Magnetic nanoparticles and targeted drug delivering. Pharmacol Res. 2010;62:144–149.
  • Sudimack J, Lee RJ. Targeted drug delivery via the folate receptor. Adv Drug Deliv Rev. 2000;41:147–162.
  • McBain SC, Yiliu HHP, Dobson J. Magnetic nonoparticles for gene and drug delivery. Int J Nanomed. 2008;3:169–180.
  • Wilczewska A, Niemirowicz K, Markiewicz KH, et al. Nanoparticles as drug delivery systems. Pharmacol Rep. 2012;64:1020–1037.
  • Cho K, Wang X, Nie S, et al. Therapeutic nanoparticles for drug delivery in cancer. Clin Cancer Res. 2008;14:1310–1316.
  • Hamidi M, Rafiei P, Azadi A, et al. Encapsulation of valproate-loaded hydrogel nanoparticles in intact human erythrocytes: a novel nano-cell composite for drug delivery. J Pharm Sci. 2011;100:1702–1711.
  • Hu CMJ, Zhang L, Aryal S, et al. Erythrocyte membrane-camouflaged polymeric nanoparticles as a biomimetic delivery platform. PNAS. 2011;108:10980–10985.
  • Lu W, Shen Y, Xie A, et al. Green synthesis and characterization of superparamagnetic Fe3O4 nanoparticles. J Magnet Magnet Mater. 2010;322:1828–1833.
  • Lu W, Shen Y, Xie A, et al. Preparation and drug-loading properties of Fe3O4/poly(styrene-co-acrylic acid) magnetic polymer nanocomposites. J Magnet Magnet Mater. 2013;345:142–146.
  • Tijsen CJ, Kolk HJ, Stamhuis EJ, et al. An experimental study on the carboxymethylation of granularpotatostarch in non-aqueous media. Carbohydr Polym. 2001;45:219–226.
  • Lu DX, Wen XT, Liang J, et al. Novel pH-sensitive drug delivery system based on natural polysaccharide for doxorubicin release. Chin J Polym Sci. 2008;26:369–374.
  • Joullié MM, Lassen KM. 2010. Evolution of amide bond formation. USA: Arkat, Inc.
  • Pourjavadi A, Hosseini S, Alizadeh M, et al. Magnetic pH-responsive nanocarrier with long spacer length and high colloidal stability for controlled delivery of doxorubicin. Colloids Surf B Biointerfaces. 2014;116:49–54.
  • Fang RH, Hu CMJ, Chen KNH, et al. Lipid-insertion enables targeting functionalization of erythrocyte membrane-cloaked nanoparticles. Nanoscale. 2013;5:8884–8888.
  • Gupta N, Patel B, Ahsan F. Nano-engineered erythrocyte ghosts as inhalational carriers for delivery of fasudil: preparation and characterization. Pharm Res. 2014;31:1553–1565.
  • Cole AJ, David AE, Wang J, et al. Polyethyleneglycol modified, cross-linked starch coated iron oxide nanoparticles for enhanced magnetic tumor targeting. Biomaterials. 2011;32:2183–2193.
  • Semete B, Booysen L, Kalombo L, et al. Effects of protein binding on the biodistribution of PEGylated PLGA nanoparticles post oral administration. Int J Pharm. 2012;424:115–120.
  • Bradford MM. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem. 1976;72:248–254.
  • Mayer A, Vadon M, Rinner B, et al. The role of nanoparticle size in hemocompatibility. Toxicology. 2009;258:139–147.
  • Yallapu MM, Chauhan N, Othman SF, et al. Implications of protein corona on physico-chemical and biological properties of magnetic nanoparticles. Biomaterials. 2015;46:1–12.
  • Ak G, Yılmaz H, Hamarat SS. Preparation of magnetically responsive albumin nanospheres and in vitro drug release studies. Artif Cells Nanomed Biotechnol. 2014;42:18–26.
  • Ak G, Sanlier SH. Synthesis of folate receptor targeted and doxorubicin coupled chemotherapeutic nanoconjugate and research into its medical applications. Prep Biochem Biotech. 2012;42:551–563.
  • Alhareth K, Vauthier C, Gueutin C, et al. HPLC quantification of doxorubicin in plasma and tissues of rats treated with doxorubicin loaded poly(alkylcyanoacrylate) nanoparticles. J Chromatogr B. 2012;887–888:128–132.
  • Kim JO, Kabanov AV, Tatiana K. Polymer micelles with cross-linked polyanion core for delivery of a cationic drug doxorubicin. J Control Release. 2009;138:197–204.
  • Wang Z, He Q, Zhao W, et al. Tumor-homing, pH- and ultrasound-responsive polypeptide-doxorubicin nanoconjugates overcome doxorubicin resistance in cancer therapy. J Control Rel. 2017;264:66–75.
  • Silva SW, Melo TFO, Soler MAG, et al. Stability of citrate-coated magnetite and cobalt–ferrite nanoparticles under laser irradiation: a raman spectroscopy investigation. IEEE Trans Magnet. 2003;39:2645–2647.
  • Jiang JS, Gan ZF, Yang Y. A novel magnetic fluid based on starch-coated magnetite nanoparticles functionalized with homing peptide. J Nanopart Res. 2009;11:1321–1330.
  • Zhang L, He R, Gu H. Oleic acid coating on the monodisperse magnetite nanoparticles. Appl Surf Sci. 2005;253:2611–2617.
  • Easo SL, Mohanan PV. Dextran stabilized iron oxide nanoparticles: synthesis, characterization and in vitro studies. Carbohydr Polym. 2013;92:726–732.
  • Nicolas J, Mura S, Brambilla D. Design, functionalization strategies and biomedical applications of targeted biodegradable/biocompatible polymer-based nanocarriers for drug delivery. Chem Soc Rev. 2013;42:1147–1235.
  • Zhang K, Chen Z, Wei J, et al. A study on one-step laser nanopatterning onto copper–hydrazone-complex thin films and its mechanism. Phys Chem Chem Phys. 2017;19:13272–13280.
  • Dobrovolskaia MA, Aggarwal P, Hall JB, et al. Preclinical studies to understand nanoparticle ınteraction with the immune system and its potential effects on nanoparticle biodistribution. Mol Pharm. 2008;5:487–495.
  • Kievit FM, Wang FY, Fang C, et al. Doxorubicin loaded iron oxide nanoparticles overcome multidrug resistance in cancer in vitro. J Control Release. 2011;152:76–83.
  • Domcke S, Sinha R, Levine DA, et al. Evaluating cell lines as tumour models by comparison of genomic profiles. Nat Comms. 2013;4:1–10.
  • Wang H, Wang S, Liao S, et al. Folate-targeting magnetic core–shell nanocarriers for selective drug release and imaging. Int J Pharm. 2012;430:342–349.
  • Wang L, Neoh KG, Kang ET, et al. Multifunctional polyglycerol-grafted Fe3O4@SiO2 nanoparticles for targeting ovarian cancer cells. Biomaterials. 2011;32:2166–2173.
  • Nukolova VN, Obero SH, Cohe SM, et al. Folate decorated nanogels for targeted therapy of ovarian cancer. Biomaterials. 2011;32:5417–5426.
  • Yang T, Li B, Qi S, et al. Co-delivery of doxorubicin and mi siRNA by folate receptor targeted liposomes exhibits enhanced anti-tumor effects in vitro and in vivo. Theranostics. 2014;4:1096–1111.
  • Chiani M, Norouzian D, Shokrgozar MA, et al. Folic acid conjugated nanoliposomes as promisingcarriers for targeted delivery of bleomycin. Artif Cells Nanomed Biotechnol. 2017 [Jun 23]; [7 p.]. DOI:https://doi.org/10.1080/21691401.2017.1337029
  • Corona G, Giannini F, Fabris M, et al. Role of folate receptor and reduced folate carrier in the transport of 5-methyltetrahydrofolic acid in human ovarian carcinoma cells. Int J Cancer. 1998;75:125–133.
  • Li F, Zhang H, Gu C, et al. Self-assembled nanoparticles from folate-decorated maleilated pullulan–doxorubicin conjugate for improved drug delivery to cancer cells. Polym Int. 2013;62:165–171.
  • Elbialy NS, Fathy MM, Khalil W. Doxorubicin loaded magnetic gold nanoparticles for in vivo targeted drug delivery. Int J Pharm. 2015;490:190–199.
  • Wang F, Wang Y, Ma Q, et al. Development and characterization of folic acid-conjugated chitosan nanoparticles for targeted and controlled delivery of gemcitabinein lung cancer therapeutics. Artif Cells Nanomed Biotechnol. 2016;45:1530–1538.
  • Zhang L, Lu J, Jin Y, et al. Folate-conjugated beta-cyclodextrin-based polymeric micelles with enhanced doxorubicin antitumor efficacy. Colloids Surf B Biointerfaces. 2014;122:260–269.
  • Meng H, Xue M, Xia T, et al. Use of size and a copolymer design feature to improve the biodistribution and the enhanced permeability and retention effect of doxorubicin-loaded mesoporous silica nanoparticles in a murine xenograft tumor model. ACS Nano. 2011;5:4131–4144.
  • Sahu BD, Kumar JM, Kuncha M, et al. Baicalein alleviates doxorubicin induced cardiotoxicity via suppression of myocardial oxidative stress and apoptosis in mice. Life Science. 2016;144:8–18.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.